ArticleEye (London, England)2024

Sustained disease control with aflibercept 8 mg: a new benchmark in the management of retinal neovascular diseases.

Jean-François Korobelnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.